Tachyarrhythmia |
Medtronic Steroid-Eluting ICD Leads
Clinical Results
| Sprint Lead | 69471 | 69442 | 69323 | 69424 | 69435 | 69456 |
|---|---|---|---|---|---|---|
| Lead Survival Probability7 | not applicable | 100% (>30 days)8 |
99% (42 months) |
99% (33 months) |
97% (33 months) |
99% (30 months) |
| Single-lead implant success | 100% (n=80) | 100% (n=112) | 98% (n=114 of 116) | 100% (n=98) | 94% (n=61 of 66) | 100% (n=78) |
| Mean DFT | 6 J (median) (n=79) | 9 J (median) (n=99) | 9.4 J (n=94) | 8.4 J (n=94) | 10.3 J (n=56) | 8.2 J (n=67) |
| Patients with DFTs < 9 J | 73% (n=58 of 79) |
73% (n=72 of 99) |
64% (n=60 of 94) |
76% (n=71 of 94) |
54% (n=30 of 56) |
78% (n=52 of 67) |
| Patients with DFTs < 15 J | 95% (n=75 of 79) |
96% (n=95 of 99) |
92% (n=86 of 94) |
95% (n=89 of 94) |
89% (n=50 of 56) |
96% (n=64 of 67) |
| Spontaneous episode efficacy of ventricular origin | 99% | 99% | 96% | 100% | 100% | 100% |
| Lead-related complications | 1% | 3% | 3% | 2% | 2% | 0% |
References
- Medtronic Sprint Quattro Secure™ Model 6947 ICD Lead Clinical Study
- Medtronic Sprint Quattro™ Model 6944 ICD Lead Clinical Study
- Medtronic Sprint 6932 Clinical Study
- Medtronic Sprint 6942 Clinical Study
- Medtronic Sprint 6943 Clinical Study
- Medtronic Sprint 6945 Clinical Study
- Medtronic Tachyarrhythmia Product Performance Report. August 1, 2001
- Early Sprint Quattro™ 6944 TCSS chronic data (>30 days) show cumulative survival of 100%
Additional Information
|
©Medtronic, Inc. 2008 • Contact Medtronic • Privacy Statement • Terms of Use • Site Map